Ricky Goldwasser
Stock Analyst at Morgan Stanley
(2.38)
# 722
Out of 5,327 analysts
338
Total ratings
56.33%
Success rate
23.68%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
DOCS Doximity | Maintains: Equal-Weight | 71 60 | 57.71 | 3.97% | 10 | Apr 24, 2025 | |
UNH UnitedHealth Group | Maintains: Overweight | 664 563 | 409.18 | 37.59% | 16 | Apr 22, 2025 | |
CRL Charles River | Maintains: Equal-Weight | 220 184 | 117.29 | 56.88% | 20 | Feb 5, 2025 | |
LH Labcorp Holdings | Maintains: Overweight | 260 270 | 240.34 | 12.34% | 15 | Dec 17, 2024 | |
ACCD Accolade | Maintains: Equal-Weight | 6 5 | n/a | n/a | 17 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 6.55 | 52.67% | 8 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 8 6 | 4.66 | 18.03% | 9 | Nov 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 5 8 | 13.13 | -42.88% | 6 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 160 8 | n/a | n/a | 10 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 12 | 17.43 | -31.15% | 8 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 94 73 | 59.27 | 23.17% | 10 | Aug 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 145 145 | 178.52 | -18.78% | 17 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 176 190 | n/a | n/a | 19 | Aug 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 365 365 | 319.98 | 14.07% | 7 | Jul 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 403 420 | 707.43 | -40.63% | 22 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 140 120 | 7.27 | 1550.62% | 7 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | n/a | n/a | n/a | 10 | Nov 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 549 620 | 259.35 | 139.06% | 11 | Oct 31, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 18 | n/a | n/a | 6 | Oct 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 485 500 | 413.44 | 20.94% | 2 | Oct 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 127 124 | 65.02 | 90.71% | 9 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 296 318 | 337.32 | -5.73% | 11 | Aug 17, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 74 70 | 139.84 | -49.94% | 16 | Jul 14, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 43 39 | 10.92 | 257.14% | 14 | Jul 6, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 607 533 | n/a | n/a | 9 | Jun 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 24 14 | n/a | n/a | 6 | Feb 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 85 95 | n/a | n/a | 11 | Dec 21, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 25 | 30.88 | -19.04% | 1 | Feb 4, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 115 135 | n/a | n/a | 8 | Feb 3, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 14 18 | n/a | n/a | 6 | Jan 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 182 195 | 153.42 | 27.1% | 6 | Oct 21, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 89 91 | n/a | n/a | 6 | Jul 8, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 128 135 | n/a | n/a | 3 | Dec 3, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 96 121 | n/a | n/a | 1 | Nov 9, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | n/a | n/a | n/a | 1 | May 11, 2017 |